Latest / Deep Values: Value Investing Deep Dives / UnitedHealth Group (UNH) Q2 2025 Earnings Exposed: Valuation, Growth, Risks Analysis
Transcript
- 0:00Welcome to the Deep Dive. We're here to take complex
- 0:02information, pull out the key insights and help you get really
- 0:06well informed fast. That's the goal.
- 0:09Cut through the noise. Exactly.
- 0:11And today we're tackling a topic that affects pretty much
- 0:14everyone Healthcare specifically.
- 0:17One of the absolute giants in the space, United Health Group,
- 0:21or UNH. A name many will recognize?
- 0:24Definitely, yeah. And you might have seen some
- 0:26headlines recently about volatility and big healthcare
- 0:29stocks. UNH itself actually took a
- 0:31pretty significant dip. That certainly caught the
- 0:34market's attention. So our mission today is to get
- 0:37behind those headlines. We're digging into a detailed
- 0:39research report on UNH to, you know, extract the essential
- 0:42takeaways. Right to understand the why
- 0:44behind the numbers. We want to help you understand
- 0:46its recent performance, how its huge operations actually work,
- 0:50the challenges it's facing, and maybe surprisingly, what its
- 0:53potential value might actually be.
- 0:55And just to be clear, this whole conversation is grounded in that
- 0:58deep research report. That's our source material.
- 1:01Absolutely. So let's explore why UNH stocks
- 1:04stumbled and what that might tell us about these massive
- 1:06healthcare businesses overall. Sounds good.
- 1:09Market reactions can be quick, but the real story often lies
- 1:11deeper. Understanding that underlying
- 1:13why is well, it's crucial if you want genuine insight.
- 1:17OK. So let's start right there with
- 1:18the immediate picture. UNH SQ22025 earnings, the
- 1:22results that caused those ripples, they reported revenue
- 1:26of $111.62 billion. Now, that's actually up 13% from
- 1:31the year before and it it slightly beat what analysts were
- 1:35expecting. Yeah, the top line, the revenue
- 1:37looked pretty solid, which makes the reaction maybe a bit
- 1:40confusing at first glance. So if revenue was OK, what
- 1:43spooked the market? What was the culprit?
- 1:45It really came down to the bottom line.
- 1:46The adjusted earnings per share or EPS came in at $4.08 and that
- 1:51missed the consensus estimate, which was around $4.45, OK.
- 1:55And the gap earnings, the sort of unadjusted profit figure was
- 1:58$3.74 per share, so a definite miss on profitability.
- 2:02And why does that happen? What drove the miss?
- 2:04The company pointed directly to what they called an elevated
- 2:07medical cost trend. Basically, patients are using
- 2:10more healthcare services than they planned for, especially
- 2:12outpatient care and visits to the doctor.
- 2:14Got it. So more people needing care that
- 2:17directly hits their profit margins.
- 2:19Exactly. It pushes up their medical care
- 2:21ratio. That's the slice of their
- 2:23premium revenue that goes straight out to pay for medical
- 2:25costs. That ratio jumped to about 84.8%
- 2:30in Q2, up from 84.3% the year before.
- 2:33Not a huge jump numerically, but enough to matter a lot at their
- 2:37scale. Right.
- 2:37And that squeeze the overall operating margin?
- 2:39Precisely. It contracted down to about 3.7%
- 2:43from around 4.3% a year ago. So less profit on each dollar of
- 2:46revenue. And this wasn't just a 1/4
- 2:48issue, was it? They actually lowered their
- 2:50outlook for the whole year. That's right.
- 2:52They trimmed their full year 2025 revenue forecast slightly,
- 2:56but the bigger hit was on earnings.
- 2:58They significantly cut their adjusted EPS guidance to at
- 3:01least $16. Wow, compared to what analysts
- 3:04thought before. Yeah, analysts were expecting
- 3:06closer to $20.90. So that's a substantial cut and
- 3:11you know, the market reacted accordingly.
- 3:13The stock dropped over 5% after that news.
- 3:15Makes sense. They said they expect these
- 3:17higher realized and anticipated care trends to continue for the
- 3:21rest of 2025. But, and this is important, they
- 3:25also said they expect earnings growth to resume in 2026.
- 3:28OK. So they see it as more of a
- 3:29short term pressure. That seems to be the message.
- 3:32It's a distinction worth noting. The profit miss grab the
- 3:35headlines, Absolutely. But that underlying revenue
- 3:38growth is still there. It shows they can still expand
- 3:41even when costs are tricky. So short term margin pain, but
- 3:44maybe not a long term collapse of the business engine itself.
- 3:47That's a good way to put it. The capacity to generate revenue
- 3:49seems intact, even if profitability is taking a
- 3:53temporary hit. OK, that gives us the immediate
- 3:55picture. But to really understand, UNH,
- 3:57we need to look under the hood, right?
- 3:59How does this giant actually work?
- 4:01How does it make money? Right, because it's not just one
- 4:04thing. United Health Group basically
- 4:06runs on two massive engines. It's a dual business model. 2
- 4:09engines. OK, what are they?
- 4:10First, you have United Healthcare or UHC.
- 4:13That's the health insurance side.
- 4:14It brought in about 54% of their revenue in 2024.
- 4:18We're talking almost $300 billion.
- 4:19Just massive, yeah. And that covers different types
- 4:22of insurance. Oh yeah, everything.
- 4:23Employer plans, individual plans, Medicare, Medicaid, even
- 4:27some global business. Their Medicare and retirement
- 4:30segment alone is enormous, nearly $140 billion in revenue
- 4:36itself. OK, so UHC is the insurance
- 4:38engine. What's the second engine?
- 4:39That's Optum. This is their health services
- 4:41business, and it's huge too, about 46% of 2024 revenue,
- 4:46around $253 billion. And it grew faster than the
- 4:50insurance side, up 12% year over year.
- 4:52Health services? What does that actually include?
- 4:54Well, Optum itself is kind of like 3 businesses in one.
- 4:57You've got Optum Health, that's actual care delivery, think
- 4:59clinics, surgery centers, doctors groups focusing
- 5:02increasingly on value based care.
- 5:04And there's Optima Rex, that's their pharmacy benefit manager
- 5:07or PBM. Huge scale there too.
- 5:09They process something like 1.6 billion prescriptions in 2024.
- 5:12Wow. And the third part.
- 5:14Opto Insight, that's the data and tech arm.
- 5:17They provide healthcare, analytics, technology platforms,
- 5:19consulting services. They had a big contract backlog
- 5:23over $32 billion, showing future demand.
- 5:26So the real power here, as the report suggests, is how these
- 5:30two sides, UHC insurance and Optum services, work together,
- 5:34right? Exactly, that's the core of
- 5:36their strategy. It's called integration.
- 5:38A UHC member might see an Optum Dr. If their prescription filled
- 5:42via Optum RX and their care might be managed using Optum
- 5:46Insight data. So they try to keep the whole
- 5:48healthcare journey sort of within the UNH ecosystem.
- 5:51Precisely. It helps them manage costs
- 5:53better, potentially coordinate care more effectively, and
- 5:56capture more of the total healthcare spending.
- 5:59It's a big competitive advantage.
- 6:00A strategic Moat, really. Hard for others to replicate
- 6:03that scale and integration. Very hard, and the scale is just
- 6:06staggering. You mentioned 50 million
- 6:07members. They're also the largest
- 6:09employer of physicians in the US, around 400,000 employees.
- 6:13That's like the population of a decent sized city just running.
- 6:16The company itself must be incredibly complex.
- 6:18Absolutely. But connecting it back to the
- 6:21big picture, this diversified, integrated model is designed to
- 6:24give them resilience, efficiency, and theoretically
- 6:27better outcomes. It's fundamental to how they
- 6:30operate. It sounds like a powerful model,
- 6:32but you know, even giants face challenges.
- 6:34What kind of Rapids is UNH navigating right now, and what
- 6:38might be further downstream? Yeah.
- 6:40No company is immune to risk. We can think about it in terms
- 6:43of short term headwinds and longer term maybe more
- 6:46structural risks. OK.
- 6:48Let's start with the short term ones.
- 6:49We already talked about the higher medical costs.
- 6:51Right. That's number one.
- 6:52Right now, that surgeon care, especially stuff people put off
- 6:54during the pandemic like seniors getting surgeries, that's
- 6:57hitting their claims costs and margins hard in 24 and 25.
- 7:01But again, they expect that to ease up in 2026.
- 7:04So potentially temporary. What else in the short term?
- 7:07Well, they're always regulatory tweaks, recent changes to how
- 7:11Medicare Advantage plans are paid and states rechecking who's
- 7:15eligible for Medicaid after the pandemic emergency ended.
- 7:18Those things can temporarily affect enrollment numbers or
- 7:21revenue growth. Like their Medicaid numbers
- 7:23dipped a bit. Exactly dropped by about 400,000
- 7:25in 2024. Also, you know, broader economic
- 7:29factors. If there's a recession, that
- 7:31could hurt their commercial insurance enrollment.
- 7:33Inflation effects their costs, two supplies, labor, drugs.
- 7:37And there been some leadership changes too, right?
- 7:39That adds uncertainty. Yeah, that's definitely a
- 7:41factor. Steven Hemsley returning as CEO
- 7:44after Andrew Witty left unexpectedly.
- 7:47Plus the tragic death of the UHCCEO Brian Thompson.
- 7:50Leadership transitions always bring a bit of short term
- 7:53uncertainty, though Hemsley knows the company inside out,
- 7:57which should help stabilize things.
- 7:58OK. Those are the near term bumps.
- 8:00What about the bigger long term risks?
- 8:02The structural stuff? Those are probably more
- 8:04significant for the Longview. Regulatory and political risk is
- 8:08always there for a company like UNH.
- 8:10It's just part of being the biggest player in U.S.
- 8:12healthcare. Like talk about Medicare for
- 8:14all. Exactly.
- 8:15Or serious drug price controls that could really squeeze Optum
- 8:19RX. Or just generally stricter
- 8:22oversight of Medicare Advantage where they're huge.
- 8:24There's also ongoing DOJ investigation into some Medicare
- 8:27Advantage payment practices, not just UNH, but the industry and
- 8:32antitrust scrutiny is real. Because they're so big and
- 8:35buying up doctor groups in clinics.
- 8:36Right. Regulators worry about the
- 8:38consolidation of insurance and care delivery under one roof.
- 8:42Could that stifle competition or limit patient choice?
- 8:45That's a constant question they face.
- 8:46What else long term? The fundamental issue of
- 8:49healthcare costs in the US If spending keeps rising faster
- 8:52than the economy grows, the pressure from employers,
- 8:55government, everyone to control costs will just become
- 8:58permanent. That could lead to backlash
- 9:00against insurers and PBMS. And technology, could they be
- 9:03disrupted? It's always a risk.
- 9:06Even though UNH invests heavily in tech via Ocktumen site, new
- 9:10care models like telehealth advancements or new data
- 9:13platforms could emerge and challenge their position and
- 9:16finally, managing their massive workforce and relationships with
- 9:19doctors and hospitals. Keeping costs down without
- 9:22alienating providers is a perpetual balancing act.
- 9:26So while things like the current cost spike are immediate
- 9:29problems, the bigger questions are about how healthcare itself
- 9:32evolves. Precisely.
- 9:33And UNH is whole. Integrated strategy is in many
- 9:37ways their attempt to navigate and shape that evolution to
- 9:40prove their value in a system that's under constant pressure
- 9:43to reform. OK, let's dig into their
- 9:45spending a bit more than nuts and bolts.
- 9:48How do their costs breakdown? The biggest piece by far is
- 9:51medical claims. That's the money they pay out
- 9:53from members healthcare. In 2024 it was about 85.5% of
- 9:57their premium. Revenue $0.85 of every premium
- 9:59dollar going straight to care. Pretty much.
- 10:02And these costs are highly variable.
- 10:03If more people get sick or need procedures, these costs go up
- 10:06directly. That's why the recent spike hit
- 10:08their profits so fast, right? What about their own operating
- 10:11costs running the business? That's the SG and a selling,
- 10:14general and administrative costs.
- 10:17I think salaries for those 400,000 employees, technology
- 10:20systems, rent, marketing, all that.
- 10:23In 2024 it was around 13.2% of revenue.
- 10:27And are those costs fixed or variable?
- 10:30They're more fixed, or what you might call STEP fixed.
- 10:32The cost of their big IT platform doesn't double if they
- 10:36add one more member, right? It scales more slowly.
- 10:39So as they get bigger, they can spread those fixed costs over
- 10:41more people. Exactly.
- 10:43That's called fixed cost leverage and UNH has been pretty
- 10:46good at this. As the membership grew
- 10:48significantly over the last decade or so, their SGNA cost
- 10:51per member actually came down. That seems like a key advantage
- 10:55of their scale. It absolutely is.
- 10:56It helps them maintain their margins even when medical costs
- 10:59fluctuate. Like now, they can manage the
- 11:02medical cost side through their provider networks and care
- 11:04management. And they get efficiency on the
- 11:06operating cost side through scale.
- 11:08It's crucial for their resilience.
- 11:10So who's actually steering this massive ship?
- 11:12Let's talk leadership. There have been some changes as
- 11:14you mentioned. Yes, Steven Hemsley is back in
- 11:17the CEO Chair as of mid 2025. He was CEO before from 2006 to
- 11:222017, a period of huge growth including really building out
- 11:25Optum. He's known for being very
- 11:27operationally focused. And the CFO?
- 11:29John Rex has been CFO since 2016, so he provides important
- 11:33continuity through these changes.
- 11:35And at the head of the United Healthcare Insurance division is
- 11:38Tim Knoll, an internal veteran who took over in January 2025
- 11:42after the tragic passing of Brian Thompson.
- 11:44How's the track record generally been?
- 11:46You said the recent earnings miss was rare.
- 11:48Historically, yes, they've generally had a strong record of
- 11:51execution, often meeting or beating their own forecasts.
- 11:55This recent stumble is definitely an exception rather
- 11:57than the rule. But there have been some
- 11:58questions, right, about transparency.
- 12:01There have been, for instance, there's a class action lawsuit
- 12:03from 2025 alleging leadership misled investors about rising
- 12:07costs. And that DOJ antitrust probe we
- 12:10mentioned, the news apparently broke in the media before the
- 12:12company formally disclosed it. And there were reports of some
- 12:15executive stock sales around that time.
- 12:17OK, that does raise an eyebrow. How are the leaders incentivized
- 12:21though? Are their interests aligned with
- 12:23shareholders? That's a key point.
- 12:25A very large chunk of their pay comes from stock and options.
- 12:29Hemsley's return package, for example, included a huge $60
- 12:32million stock award that vests over several years, far
- 12:36outweighing his base salary. So he does well only if the
- 12:39stock price does well over time. Exactly.
- 12:42It creates strong alignment with long term shareholder value and
- 12:45historically the company has reinvested effectively, making
- 12:49acquisitions like Catamaran that ultimately boosted the share
- 12:52price significantly. So despite some recent
- 12:55transparency questions, the structure generally points
- 12:58towards long term. Alignment.
- 12:59Generally, yes. The long tenure of people like
- 13:02Hemsley and Rex, combined with that heavy equity component in
- 13:05their pay suggests they are deeply invested in the company's
- 13:08long term success. How they navigate these current
- 13:11challenges, though, will certainly be a major test for
- 13:13them. Makes sense Now who actually
- 13:15owns this giant and what does the company do with the profits
- 13:18it generates? Well, the ownership is dominated
- 13:20by big institutions. You know, the huge index fund
- 13:23managers, Vanguard, BlackRock, State Street.
- 13:27Together they own something like 20% or more.
- 13:29So mostly passive investors. A large chunk is passive, yes,
- 13:34but there are also significant active institutional holders
- 13:37like Capital Group and Fidelity who take a more direct view on
- 13:40the company's strategy and valuation.
- 13:43And do these shareholders seem supportive of management?
- 13:45Based on recent votes yes. At the 2025 annual meeting, for
- 13:49instance, all the directors were re elected easily.
- 13:52Executive pay was approved by a large margin.
- 13:54A shareholder proposal about limiting executive severance
- 13:57packages was voted down. So it suggests a general level
- 14:00of trust in the current leadership and board.
- 14:02And how do they return profits to these owners?
- 14:04Dividends, obviously, but anything.
- 14:06Else they are very active with share buybacks alongside the
- 14:09dividend. They bought back around $9
- 14:11billion worth of shares in 2024 and another $3 billion just in
- 14:15the first quarter of 2025. They're buying their own stock
- 14:18back from the market. Exactly.
- 14:21The goal is partly to offset the new shares created by employee
- 14:24stock options, but also to actively reduce the total number
- 14:28of shares outstanding. Over the last decade, the share
- 14:31count has shrunk by about 9%. And shrinking the share count
- 14:35makes each remaining share represent a bigger piece of the
- 14:38company, potentially boosting earnings per share.
- 14:41That's the idea, and it's interesting management actually
- 14:44increase the buybacks when the stock dipped in early 2025.
- 14:48That can be seen as a signal of confidence that they believe the
- 14:51stock was undervalued at those prices.
- 14:53So stable institutional ownership plus a consistent
- 14:57strategy of returning capital through dividends and buybacks.
- 15:00It points to a focus on long term shareholder value.
- 15:03That seems to be the case. The buybacks, especially during
- 15:06the dip, suggest a strong internal belief in the company's
- 15:09underlying value. OK.
- 15:10Let's bring this back to value investing.
- 15:12Specifically, have any famous value investors taking a
- 15:15position in UNH? What can their actions tell us?
- 15:18It's actually quite revealing to look at that even Warren
- 15:21Buffett's Berkshire Hathaway dipped their toes in.
- 15:23They bought shares around 2018, maybe averaged around $280 a
- 15:27share. Oh, interesting, Did did hold
- 15:29on. No, they actually sold out by
- 15:312020. Probably somewhere in the $300.
- 15:34Likely felt it wasn't significantly undervalued
- 15:36anymore at that point. OK, what about others known for
- 15:39value? Well, look at Vulcan Value
- 15:41Partners. They actually sold UNH back in
- 15:43late 2019. Also near $280, probably for
- 15:47similar valuation reasons. But here's the fascinating part.
- 15:50They started buying back in late 2024, and again in Q22025 when
- 15:56the price fell sharply. Why?
- 15:57What was their reasoning? They specifically cited the
- 15:59valuations, saying the PE ratio had fallen to an 11 year low.
- 16:03They saw the price drop as an opportunity.
- 16:06And any others acting similarly. Dodge and Cox, another very
- 16:09respected long term value shop. They've held UNH for a while and
- 16:12they actually increased their stake in 2025 during the
- 16:15downturn. Also pointing to valuation.
- 16:17Yeah, they noted the forward PE was hitting those same 11 year
- 16:20lows around 13 times expected earnings.
- 16:23So they're not just holding, they're adding, showing real
- 16:25conviction through the negativity.
- 16:27So the pattern seems to be value investors buy when the market
- 16:31gets pessimistic and the price disconnects from what they see
- 16:35as the long term value and maybe trim when it gets expensive.
- 16:38That's exactly it. Many seem to be holding firm or
- 16:41actively buying around these $280 levels, suggesting they
- 16:45believe the market is overreacting to the short term
- 16:48earnings pressure. They see the long term
- 16:49fundamentals as intact. They're capitalizing on that
- 16:52pessimism. Seems like it.
- 16:54It shows a deep conviction that the intrinsic value is
- 16:56significantly higher than the current market price.
- 16:59OK, then let's try to quantify that.
- 17:00The big So what using a method favored by Buffett himself.
- 17:05What could UNH actually be worth?
- 17:07Right. Let's unpack that using a
- 17:08simplified discounted cash flow or DCF approach.
- 17:12We focus on free cash flow or FCF, basically the cash leftover
- 17:16for owners after running the business and reinvesting.
- 17:18And what assumptions do we make? We'll use a 10% discount rate
- 17:21that's a common hurdle rate, the minimum return and investor
- 17:24might demand and we'll look for a margin of safety say 30% to
- 17:2750% as a for against being wrong.
- 17:30OK. How has their FCF looked
- 17:32historically? Pretty strong growth.
- 17:34It went from about $8 billion in 2015 up to nearly $26 billion in
- 17:392023. That's roughly a 15% compound
- 17:43annual growth rate. It did dip in 2024 down to about
- 17:46$21 billion, reflecting some of those pressures we discussed.
- 17:49So if we project that forward using different growth rates.
- 17:52Let's run a few scenarios. First, a conservative one.
- 17:55Let's say FCF only grows at 5% per year for the next 10 years,
- 17:59much slower than history. OK, what does that give us?
- 18:02Even with that slow growth, the calculated intrinsic value comes
- 18:05out around $360.00 per share compared to the current price of
- 18:08say, $282. That's already a margin of
- 18:11safety of about 22%. So even conservative assumptions
- 18:15suggest it's undervalued. What about a more average case?
- 18:17Right, let's try an average base scenario.
- 18:19Assume FCF grows at 12% a year for 10 years, closer to their
- 18:23long term track record but still below the peak years.
- 18:26And the value then. That calculation puts the
- 18:28intrinsic value around $630 per share.
- 18:31Now compared to $282, you're looking at a margin of safety
- 18:34over 55%. That's substantial.
- 18:36The current price is even below what you'd consider a 50% margin
- 18:39of safety price. That's a huge potential gap
- 18:43between price and value. It is.
- 18:45And just for perspective, an optimistic scenario with 18%
- 18:49growth closer to their best years yields an intrinsic value
- 18:52over $1000 per share. The current price looks
- 18:54extremely low in that light. So, flipping it around, what
- 18:57kind of return could an investor expect buying at 282%?
- 19:01Well, if UNH achieves that average 12% FCF growth, the
- 19:05model suggests an expected annual return of around 17.2%.
- 19:09Even if they only hit the conservative to 5% growth, the
- 19:12expected return is still about 12.1%.
- 19:15Which is still above that 10% hurdle rate we talked about.
- 19:17Exactly. So in Buffett's terms, UNH at
- 19:19$282 really does appear to be selling at a significant
- 19:22discount to intrinsic value, potentially undervalued by 20%,
- 19:26maybe even up to 55% or more depending on your growth
- 19:28assumptions. And that's just the numbers.
- 19:30You also have the qualitative strengths, the business mode,
- 19:32the diversification, the dividend growth.
- 19:34Right, those factors add confidence.
- 19:36Of course, these estimates hinge on future execution, but UNHS
- 19:40history of adapting combined with this current valuation
- 19:43suggests the odds might be tilted in favor of decent
- 19:46returns even with a healthy margin of safety built in.
- 19:50OK. So to wrap up this deep dive,
- 19:51United Health Group, clearly a healthcare giant, very
- 19:55resilient, very diversified. It's facing some real short term
- 20:00cost headwinds right now. That's clear from the recent
- 20:02results and guidance cut. But it's integrated business
- 20:05model, that combination of insurance and services seems to
- 20:07provide a really strong foundation for the long run.
- 20:10That integration is key to their competitive advantage and
- 20:13potential resilience. And despite the stock taking a
- 20:15hit recently, it looks like many experienced value investors see
- 20:19this as a buying opportunity, viewing it and significantly
- 20:22undervalued. Our own intrinsic value analysis
- 20:25using that FCF method seems to back that up, suggesting
- 20:29potentially considerable upside from current levels.
- 20:31It really makes you think, doesn't it, how short term
- 20:34market noise like an earnings miss can sometimes over shadow
- 20:38the long term value of a fundamentally strong business.
- 20:41It's a classic pattern. The immediate news dominates
- 20:43while the underlying slower moving value story gets
- 20:46overlooked. So the provocative thought for
- 20:49you, the listener, is this. How can you use deep dives like
- 20:53this one to get better at telling the difference between
- 20:55temporary problems and permanent damage, between headwinds and
- 21:00structural shifts? And what does that mean for how
- 21:02you analyze information, not just investing, but in any area
- 21:05you're interested in? It's about trying to turn that
- 21:07flood of information we all face in actual usable insight.
- 21:12Applying this method, dissecting reports, finding the real
- 21:15Nuggets can help you do that. Building that framework for
- 21:18deeper understanding. Well, thank you for joining us
- 21:20on this deep dive into United Health.
- 21:21Group And just a quick reminder for everyone listening, all the
- 21:23analysis we discussed today is based on publicly available
- 21:26sources. It's for educational purposes
- 21:28only and definitely not investment advice.
- 21:31Remember to do your own research before making any decisions.
- 21:34Absolutely conduct your own due diligence.
- 21:36Thanks again for tuning in.